Understanding Blood-Based Biomarkers in Alzheimer Disease
Dr. Dan Ackerman talks with Dr. Trey Bateman about the significance of blood-based biomarkers in Alzheimer disease. Purchase Annual Meeting On Demand to get access to the recordings and the ability to claim CME through March 1, 2026. Disclosures can be found at Neurology.org.
▶︎
Diagnosis of Alzheimer Disease Using Plasma Biomarkers
▶︎
The Brain Expert: Prevent Dementia & Alzheimer's Disease (AVOID THIS FOOD) | Dr Johnson
▶︎
Blood Tests for Alzheimer’s Disease: An Overview
▶︎
New Restless Leg Syndrome Guidance
▶︎
AANP Teaching Rounds - June 25, 2025 - Blood-Based Biomarkers for Alzheimer’s and Related Disorders
▶︎
JCO PO Article Insights: Longitudinal Monitoring of Anti-EGFR Based Therapy in CRC
▶︎
45% OF DEMENTIA CASES ARE PREVENTABLE. HOW TO STOP IT BEFORE IT'S TOO LATE
▶︎
Blood-Based Biomarkers for Alzheimer’s Disease and Related Disorders
▶︎
Blood Biomarkers & Testing for Alzheimer’s Disease
▶︎
Prion Disease Clinical Trial NN112
▶︎
Diagnosing Alzheimer’s Disease in the Biomarker Era: Promises and Pitfalls | Professor Ron Petersen
▶︎
Before You Panic Over Your DEXA Score, Watch THIS
▶︎
Groundbreaking New Revelations on Alzheimer's Disease
▶︎
What is Dementia?
▶︎
Alzheimer Disease Blood Biomarkers
▶︎
Alzheimer's Dementia Progression: What Happens Next?
▶︎
June 2026 Recall: Topics on Parkinsonian Disorders
▶︎
Vitamin D: The Hormone That Can Save Your Life | Dr Michael Holick Interview
▶︎
CSF Biomarkers: Aid in the Differential Diagnosisof Alzheimer’s Disease
▶︎